LIMITED GUARANTEELimited Guarantee • October 20th, 2023 • Tianjin Kangyue Business Management Partnership (Limited Partnership) • Services-medical laboratories • New York
This Limited Guarantee (this “Limited Guarantee”), dated as of October 11, 2023, is made by CICC Healthcare Investment Fund, L.P., a partnership organized under the laws of Cayman Islands (the “Guarantor”), in favor of Genetron Holdings Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Guaranteed Party”). Unless otherwise indicated, capitalized terms used but not defined in this Limited Guarantee shall have the meanings assigned to them in the Merger Agreement (as defined below).
Re: Equity Commitment LetterEquity Commitment Letter • October 20th, 2023 • Tianjin Kangyue Business Management Partnership (Limited Partnership) • Services-medical laboratories • New York
This letter agreement sets forth the commitment of the undersigned (the “Sponsor”), subject to (i) the terms and conditions contained in an Agreement and Plan of Merger, dated as of the date hereof, by and among New Genetron Holding Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (“Parent”), Genetron New Co Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands and a wholly owned Subsidiary of Parent (“Merger Sub”) and Genetron Holdings Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”) (as may be amended, restated, supplemented or otherwise modified from time to time in accordance with its terms, the “Merger Agreement”), which provides, among other things, for the merger of Merger Sub with and into the Company, with the Company continuing as the surviving company and a wholly owned subsidiary of Parent (the “Merger”) an
INTERIM INVESTOR AGREEMENTInterim Investor Agreement • October 20th, 2023 • Tianjin Kangyue Business Management Partnership (Limited Partnership) • Services-medical laboratories • New York
This Interim Investor Agreement (the “Agreement”) is made as of October 11, 2023 by and among Mr. Sizhen Wang (the “Founder”), Tianjin Kangyue Business Management Partnership (Limited Partnership) (“Tianjin Kangyue”), CICC Healthcare Investment Fund, L.P. (“CICC Healthcare,” and together with Tianjin Kangyue, collectively, “CICC”), Surrich International Company Limited (“Wuxi Capital”), Wuxi Huihongyingkang Investment Partnership (Limited Partnership) (“Wuxi Huishan”), CCB (Beijing) Investment Fund Management Co., Ltd. (“CCB”) and Wealth Strategy Holding Limited (“Wealth Strategy”, together with CICC, Wuxi Capital, Wuxi Huishan and CCB, collectively, “Investor Members”), New Genetron Holding Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Parent”) and Genetron New Co Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Merger Sub”). The Founder and the Investor Members shall be co
Joint Filing AgreementJoint Filing Agreement • March 14th, 2022 • Tianjin Kangyue Business Management Partnership (Limited Partnership) • Services-medical laboratories
This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
ROLLOVER AND SUPPORT AGREEMENTRollover and Support Agreement • October 20th, 2023 • Tianjin Kangyue Business Management Partnership (Limited Partnership) • Services-medical laboratories • New York
This ROLLOVER AND SUPPORT AGREEMENT (this “Agreement”) is entered into as of October 11, 2023 by and between New Genetron Holding Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Parent”) and the persons set forth on Schedule A hereto (each, a “Rollover Shareholder”, and collectively, “Rollover Shareholders”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement (as defined below).
Joint Filing AgreementJoint Filing Agreement • October 20th, 2023 • Tianjin Kangyue Business Management Partnership (Limited Partnership) • Services-medical laboratories
This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same instrument.
